Consider Pioglitazone for Patients with Prediabetes and Prior Stroke

April 2016

You'll hear debate about using pioglitazone (Actos, etc) to decrease CV risk AFTER an ischemic stroke...in patients WITHOUT diabetes.

New evidence suggests pioglitazone may improve CV outcomes in patients with a prior stroke or TIA and insulin resistance or PREdiabetes.

Using pioglitazone for about 5 years prevents a second stroke or MI in 1 in 36 of these patients, and slows progression to diabetes in 1 in 26...but does not decrease overall mortality.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote